ASTHMA AND FATTY ACID IMBALANCE: IS THE OMEGA-3 SUPPLEMENT BENEFICIAL IN ASTHMA?
RSUD Kemayoran
Atma Jaya Catholic University of Indonesia
DOI:
https://doi.org/10.56943/jsh.v1i4.188Introduction. Asthma is a chronic airway inflammatory disease with the characteristic of eosinophilic infiltration, mucus hypersecretion, and airway hyper-responsiveness (AHR). Lipid mediators are one of mediators that were suggested to be involved in asthma pathophysiology. Then, the pro-inflammatory mediators initiate inflammation while pro-resolving mediators are produced at later stage in the resolution phase to bring back the cellular homeostasis. Pro-resolving mediators can be produced from omega-3 (n-3), one of the essential fatty acid needed from food. Method. This research is a literature review based on some sources like books and journals with the same topic. Result & Analysis. The relation between diet, especially fatty acid, and the risk of lung inflammatory process, such as asthma has long been suggested. The metabolites of fatty acids and the fatty acid itself become decisive factors in regulating the persistence and resolution of bronchopulmonary inflammation in asthma. The high concentration of n-3 in vitro decreases production of pro-inflammatory prostaglandins, cytokines, and ROS that play critical roles in inflammatory process. Discussion. Since asthma is known to be mainly caused by an inflammatory process, it has been hypothesized that high intake of n-3 fatty acid may be beneficial in prevention and management of asthma.
Keywords: Asthma Fatty Acid Imbalance Omega-3
Adams, S. et al. (2018) ‘Relationship between Serum Omega-3 Fatty Acid and Asthma Endpoints’, International Journal of Environmental Research and Public Health, 16(1), p. 43. Available at: https://doi.org/10.3390/ijerph16010043.
Arm, J.P. et al. (1988) ‘Effect of dietary supplementation with fish oil lipids on mild asthma.’, Thorax, 43(2), pp. 84–92. Available at: https://doi.org/10.1136/thx.43.2.84.
Bannenberg, G. and Serhan, C.N. (2010) ‘Specialized pro-resolving lipid mediators in the inflammatory response: An update’, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1801(12), pp. 1260–1273. Available at: https://doi.org/10.1016/j.bbalip.2010.08.002.
Brannan, J.D. et al. (2015) ‘The Effect of Omega-3 Fatty Acids on Bronchial Hyperresponsiveness, Sputum Eosinophilia, and Mast Cell Mediators in Asthma’, Chest, 147(2), pp. 397–405. Available at: https://doi.org/10.1378/chest.14-1214.
Dharmage, S.C., Perret, J.L. and Custovic, A. (2019) ‘Epidemiology of Asthma in Children and Adults’, Frontiers in Pediatrics, 7. Available at: https://doi.org/10.3389/fped.2019.00246.
Diamant, Z. et al. (2019) ‘Targeting lipid mediators in asthma’, Current Opinion in Pulmonary Medicine, 25(1), pp. 121–127. Available at: https://doi.org/10.1097/MCP.0000000000000544.
Dry, J. and Vincent, D. (1991) ‘Effect of a Fish Oil Diet on Asthma: Results of a 1-Year Double-Blind Study’, International Archives of Allergy and Immunology, 95(2–3), pp. 156–157. Available at: https://doi.org/10.1159/000235421.
Hamid, Q. and Tulic, M. (2009) ‘Immunobiology of Asthma’, Annual Review of Physiology, 71(1), pp. 489–507. Available at: https://doi.org/10.1146/annurev.physiol.010908.163200.
Kiecolt-Glaser, J.K. et al. (2011) ‘Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial’, Brain, Behavior, and Immunity, 25(8), pp. 1725–1734. Available at: https://doi.org/10.1016/j.bbi.2011.07.229.
Kompauer, I. et al. (2008) ‘Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults’, European Journal of Epidemiology, 23(3), pp. 175–190. Available at: https://doi.org/10.1007/s10654-007-9218-y.
Kumar, N.G. et al. (2019) ‘Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health’, Nutrients, 11(12), p. 2974. Available at: https://doi.org/10.3390/nu11122974.
Kytikova, O. et al. (2019) ‘Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma’, Medicina, 55(6), p. 284. Available at: https://doi.org/10.3390/medicina55060284.
Lang, J.E. et al. (2019) ‘Fish Oil Supplementation in Overweight/Obese Patients with Uncontrolled Asthma. A Randomized Trial’, Annals of the American Thoracic Society, 16(5), pp. 554–562. Available at: https://doi.org/10.1513/AnnalsATS.201807-446OC.
Lochner, M., Berod, L. and Sparwasser, T. (2015) ‘Fatty acid metabolism in the regulation of T cell function’, Trends in Immunology, 36(2), pp. 81–91. Available at: https://doi.org/10.1016/j.it.2014.12.005.
Luster, A.D. and Tager, A.M. (2004) ‘T-cell trafficking in asthma: lipid mediators grease the way’, Nature Reviews Immunology, 4(9), pp. 711–724. Available at: https://doi.org/10.1038/nri1438.
Mickleborough, T.D. et al. (2006) ‘Protective Effect of Fish Oil Supplementation on Exercise-Induced Bronchoconstriction in Asthma’, Chest, 129(1), pp. 39–49. Available at: https://doi.org/10.1378/chest.129.1.39.
Mickleborough, T.D., Ionescu, A.A. and Rundell, K.W. (2004) ‘Omega-3 Fatty Acids and Airway Hyperresponsiveness in Asthma’, The Journal of Alternative and Complementary Medicine, 10(6), pp. 1067–1075. Available at: https://doi.org/10.1089/acm.2004.10.1067.
Mims, J.W. (2015) ‘Asthma: definitions and pathophysiology’, International Forum of Allergy & Rhinology, 5(S1), pp. S2–S6. Available at: https://doi.org/10.1002/alr.21609.
Monga, N. et al. (2020) ‘Lipid mediators and asthma: Scope of therapeutics’, Biochemical Pharmacology, 179, p. 113925. Available at: https://doi.org/10.1016/j.bcp.2020.113925.
Nagakura, T. et al. (2000) ‘Dietary supplementation with fish oil rich in ω-3 polyunsaturated fatty acids in children with bronchial asthma’, European Respiratory Journal, 16(5), pp. 861–865. Available at: https://doi.org/10.1183/09031936.00.16586100.
Rago, D. et al. (2019) ‘Fish-oil supplementation in pregnancy, child metabolomics and asthma risk’, EBioMedicine, 46, pp. 399–410. Available at: https://doi.org/10.1016/j.ebiom.2019.07.057.
Serhan, C.N. et al. (2000) ‘Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing’, Journal of Experimental Medicine, 192(8), pp. 1197–1204. Available at: https://doi.org/10.1084/jem.192.8.1197.
Serhan, C.N. (2014) ‘Pro-resolving lipid mediators are leads for resolution physiology’, Nature, 510(7503), pp. 92–101. Available at: https://doi.org/10.1038/nature13479.
Serhan, C.N., Yacoubian, S. and Yang, R. (2008) ‘Anti-Inflammatory and Proresolving Lipid Mediators’, Annual Review of Pathology: Mechanisms of Disease, 3(1), pp. 279–312. Available at: https://doi.org/10.1146/annurev.pathmechdis.3.121806.151409.
Snyder, H. (2019) ‘Literature review as a research methodology: An overview and guidelines’, Journal of Business Research, 104, pp. 333–339. Available at: https://doi.org/10.1016/j.jbusres.2019.07.039.
Szymańska, E. et al. (2012) ‘A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake’, Metabolomics, 8(5), pp. 894–906. Available at: https://doi.org/10.1007/s11306-011-0384-2.
Villani, F. et al. (1998) ‘Effect of Dietary Supplementation with Polyunsaturated Fatty Acids on Bronchial Hyperreactivity in Subjects with Seasonal Asthma’, Respiration, 65(4), pp. 265–269. Available at: https://doi.org/10.1159/000029274.
Vos, T. et al. (2012) ‘Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010’, The Lancet, 380(9859), pp. 2163–2196. Available at: https://doi.org/10.1016/S0140-6736(12)61729-2.
Voynow, J.A. and Kummarapurugu, A. (2011) ‘Isoprostanes and asthma’, Biochimica et Biophysica Acta (BBA) - General Subjects, 1810(11), pp. 1091–1095. Available at: https://doi.org/10.1016/j.bbagen.2011.04.016.
Wendell, S.G., Baffi, C. and Holguin, F. (2014) ‘Fatty acids, inflammation, and asthma’, Journal of Allergy and Clinical Immunology, 133(5), pp. 1255–1264. Available at: https://doi.org/10.1016/j.jaci.2013.12.1087.
Yang, A. et al. (2021) ‘Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development’, Respiratory Research, 22(1), p. 204. Available at: https://doi.org/10.1186/s12931-021-01792-y.
Yang, H., Xun, P. and He, K. (2013) ‘Fish and Fish Oil Intake in Relation to Risk of Asthma: A Systematic Review and Meta-Analysis’, PLoS ONE. Edited by L.K. Rogers, 8(11), p. e80048. Available at: https://doi.org/10.1371/journal.pone.0080048.
